US Government Could Seek Over $1 Billion From J&J for Cancer Treatment Costs
NEW YORK (Reuters) - The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as ...
Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock's Fortunes Around?
Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the ...
Jermaine Johnson: I’ve been through too much to come back as an average player
The list of things that went wrong for the 2024 Jets is long enough that edge rusher Jermaine Johnson's torn Achilles got ...
J&J Tops Quarterly Profit Estimates on Cancer Drug Sales
Johnson & Johnson beat Wall Street’s fourth-quarter expectations as strong cancer drug sales compensated for a decline in ...
J&J Talc Deal Should Be Rejected in Bankruptcy, Holdouts Say
Holdout creditors who claim tainted baby powder gave them ovarian cancer urged a judge to reject Johnson & Johnson’s plan to ...
HHS eyeing over $1B from J&J for talc cancer treatments: govt. attorney
Johnson & Johnson (JNJ) faces a $1B+ reimbursement demand for cancer cases linked to talc products. Read more here.
J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.
FiercePharma6d
US government agencies file objection to J&J's $9B talc bankruptcy settlement
Two attempts by Johnson & Johnson to resolve approximately 60,000 talcum powder lawsuits through bankruptcy courts have ...
HR Dive5d
Judge dismisses 2 counts in J&J pharmacy benefits lawsuit over upcharged drugs
In its motion to dismiss, J&J asserted that the plaintiff did “not allege a concrete harm or injury-in-fact” — a claim with ...